Skip to main content

Table 3 Association between residual symptoms domains, pain and functioning

From: Residual symptoms and functioning in depression, does the type of residual symptom matter? A post-hoc analysis

 

Odds Ratio

95% Wald Confidence Limits

Age

0.990

0.975

1.005

Gender (male vs. female)

1.356

0.886

2.076

Academic degree (high vs. other)

1.580

0.949

2.629

Baseline functioning level (SOFAS)

1.049

1.031

1.067

Episode length (4–24 weeks vs. ≥ 24 weeks)

2.008

1.127

3.579

Episode lenght (≤4 weeks vs. ≥24 weeks)

2.138

1.145

3.992

Absence of residual core mood symptoms

8.728

4.553

16.730

Absence of residual insomnia symptoms

1.796

1.175

2.744

Absence of residual anxiety symptoms and absence of pain

5.257

2.445

11.300

Absence of residual anxiety symptoms and presence of pain

0.412

0.073

2.341

Absence of pain and absence of residual anxiety symptoms

21.669

3.544

132.498

Absence of pain and presence of residual anxiety symptoms

1.700

1.025

2.819

  1. Logistic regression model.
  2. SOFAS = Social and Occupational Functioning Assessment Scale;
  3. Dependent variable: normal level of functioning (SOFAS total score ≥80) after 3 months of antidepressant treatment.